期刊文献+

氯氮平、去甲氯氮平及奥氮平的高效液相色谱电化学检测特性的研究 被引量:4

Study of the Detection Characteristics of Clozapine, N-Desmethyl Clozapine and Olanzapine with High Performance Liquid Chromatograph-Electrochemical Detector
下载PDF
导出
摘要 采用高效液相色谱安培电化学检测法 ,考察了氯氮平、去甲氯氮平和奥氮平在不同 pH值流动相下的色谱分离情况及其色谱峰高与检测电压的关系。结果表明 ,氯氮平、去甲氯氮平和奥氮平的保留时间均随流动相 pH值的升高而延长 ;在pH值为 4 5 6和 5 5 6的流动相中 ,均可实现基线分离。 3种化合物的色谱峰高与检测电压之间呈典型的“S”型曲线 ,pH值升高时该曲线均左移。氯氮平、去甲氯氮平和奥氮平的检测电压必须大于产生最大氧化电流的最低电压才能得到稳定的检测电流。这种典型的“S” In order to analyze clozapine, N desmethyl clozapine and olanzapine, their detection characteristics with high performance liquid chromatograph electrochemical detector (HPLC ECD) were investigated The separation was performed on an ODS 3 column with the mobile phase of methanol and 0 1 mol/L phosphate buffer(60∶40, V/V ) The retention times of clozapine, N desmethyl clozapine and olanzapine were all prolonged with higher pH of the mobile phase These three compounds could be separated on the baseline at pH 4 56 and 5 56 The relationships of peak heights and detection voltages shown typical “S” shaped curves, and these curves shifted to the left with higher pH To get stable detection current, the detection voltages for clozapine, N desmethyl clozapine and olanzapine must be higher than 0 60 V, 0 60 V and 0 35 V at pH 4 56, and 0 48 V, 0 48 V and 0 30 V at pH 5 56, respectively The typical “S” shaped ampere volt curves were very important for the selection of suitable voltage for quantitative detection, and could be used for the qualitative detection of these three compounds
出处 《色谱》 CAS CSCD 北大核心 2000年第6期550-553,共4页 Chinese Journal of Chromatography
关键词 氯氮平 去甲氯氮平 奥氮平 HPLC 电化学检测 high performance liquid chromatography electrochemical detector ampere detection clozapine N desmethyl clozapine olanzapine
  • 相关文献

参考文献4

二级参考文献4

共引文献69

同被引文献34

  • 1冯立志.抗精神病药物血药浓度监测的意义和检测方法的研究进展[J].临床和实验医学杂志,2007,6(5):114-115. 被引量:7
  • 2李焕德 许树梧.急性中毒毒物检测与诊疗[M].长沙:湖南科学技术出版社,2001.348.
  • 3Madsen AL,Karle A,Rubin P,et al.Progressive atrophy of the frontal lobs in first-episode schizophrenia:interaction with clinical course and neuroleptic treatment[J].Acta Psychiat Scand,1999,100(5):367.
  • 4Thomson AH,Whiting B.Bayesian parameter estimation and population pharmacokinetics[J].Clin Pharmacokinet,1992,22(6):447.
  • 5Wang CY,Zhang ZJ,Li WB,et al.The Differential Effects of Steady-State Fluvoxamine on the Pharmacokinetics of Olanzapine and Clozapine in Healthy Volunteers[J].J Clin Pharmacol,2004,44(7):785.
  • 6Gex-Fabry M,Balant-Gorgia AE,Balant LP.Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions[J].Drug Saf,2001,24(13):947.
  • 7Ozdemir V,Kalow W,Okey AB,et al.Treatmentresistance to clozapine in association with ultrarapid CYPlA2 activity and the C->A polymorphism in intron 1 of the CYPlA2 gene:effect of grapefruit jnice and low-dose fluvoxamine[J].J Psychopharmacol,2001,21(6):603.
  • 8Van der Weide J,Steijns LS,van Weelden MJ.The effect of smoking and cytochrome P450 CYPlA2 genetic polymorphism on clozapine clearance and dose requirement[J].Pharmacogenetics,2003,13(3):169.
  • 9Aravagiri M,Ames D,Wirshing WC,et al.Plasma level monitoring of olanzapine in patients with schizophrenia:determination by high-performance liquid chromatography with electrochemical detection[J].Ther Drug Monit,1997,19(3):307.
  • 10Veuthey JL,Souverain S,Rudaz S.Column-switching procedures for the analysis of drugs in biologic samples[J].Ther Drug Monit,2004,26(2):161.

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部